Earnings call transcripts

Management framed the soft start as distributor inventory timing, while pointing to locked-in promotions and an expected second-half recovery to support the reaffirmed outlook.

Management framed FY2025 as broad-based, profitable growth, with Hyve, regional share gains, and strategic investments supporting continued momentum.

Management framed Q2 as early transformation progress, with commercial discipline and cost actions offsetting macro weakness while preserving cautious guidance.

Management framed 2025 as resilient amid supply constraints, while the call centered on Pratt & Whitney engine shortfalls, Spirit integration costs and a slower delivery trajectory.

Management framed the turnaround as progressing unevenly, with North America and Running leading while China remains the longest reset.

Management framed strong traffic and value execution as outweighing beef inflation, with margin recovery expected as pricing catches up and commodities ease.

Management framed market-share gains and operational execution as offsets to weak demand, with cautious optimism for 2026 improvement.

Management framed the quarter as evidence that inventory investment and customer-experience improvements are restoring growth, while acknowledging heavier cash use and lower margins.

Management framed Q2 as evidence of accelerating category growth, improving unit economics and clinical evidence that could broaden WCD use, without relying on guideline changes.

Management framed Pedro Branca as a cash-flowing, accretive addition that leaves Gold Royalty debt-free while preserving disciplined dealmaking.

Management framed AI-driven network investment as a durable, capacity-constrained inflection, with visibility improving sharply but long-term growth guidance withdrawn.

Management framed Q3 as resilient but acknowledged a sharp November deterioration, using 2026 merchandising and marketing changes to rebuild growth.